CH

Cornelia Adriana Maria Heinz

AP Astellas Pharma: 5 patents #120 of 954Top 15%
GG Ganymed Pharmaceuticals Gmbh: 3 patents #21 of 49Top 45%
📍 Oppenheim, DE: #6 of 31 inventorsTop 20%
Overall (All Time): #614,737 of 4,157,543Top 15%
8
Patents All Time

Issued Patents All Time

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
12059464 Combination therapy involving antibodies against Claudin 18.2 for treatment of cancer Ugur Sahin, Ozlem Tureci, Rita Mitnacht-Kraus, Stefan Jacobs, Magdalena Jadwiga Utsch +1 more 2024-08-13
11826402 Combination therapy involving antibodies against claudin 18.2 for treatment of metastatic pancreatic adenocarcinoma Ugur Sahin, Ozlem Tureci, Rita Mitnacht-Kraus, Stefan Woll, Stefan Jacobs 2023-11-28
10946069 Combination therapy involving antibodies against claudin 18.2 for treatment of pancreatic cancer Ugur Sahin, Ozlem Tureci, Rita Mitnacht-Kraus, Stefan Woll, Stefan Jacobs 2021-03-16
10813996 Combination therapy involving antibodies against Claudin 18.2 for treatment of cancer Ugur Sahin, Ozlem Tureci, Rita Mitnacht-Kraus, Stefan Jacobs, Magdalena Jadwiga Utsch +1 more 2020-10-27
10314890 Combination therapy involving antibodies against claudin 18.2 for treatment of pancreatic cancer Ugur Sahin, Ozlem Tureci, Rita Mitnacht-Kraus, Stefan Woll, Stefan Jacobs 2019-06-11
10022444 Combination therapy involving antibodies against Claudin 18.2 for treatment of cancer Ugur Sahin, Ozlem Tureci, Rita Mitnacht-Kraus, Stefan Jacobs, Magdalena Jadwiga Utsch +1 more 2018-07-17
9770487 Combination therapy involving antibodies against claudin 18.2 for treatment of pancreatic adenocarcinoma Ugur Sahin, Ozlem Tureci, Rita Mitnacht-Kraus, Stefan Woll, Stefan Jacobs 2017-09-26
9433675 Combination therapy involving antibodies against claudin 18.2 for treatment of cancer Ugur Sahin, Ozlem Tureci, Rita Mitnacht-Kraus, Stefan Jacobs, Magdalena Jadwiga Utsch +1 more 2016-09-06